Design Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | -14.7M | 14.6M | 152K | 0 | 0 | 0 | 151K |
| Gross Profit | 0 | 14.7M | -14.6M | -152K | 0 | 0 | 0 | -151K |
| R&D Expenses | 14.4M | 13.4M | 14.6M | 15.7M | 15.4M | 12.2M | 11.9M | 10.4M |
| Operating Expenses | 19.7M | 32.9M | 4.7M | 21.4M | 20.4M | 16.7M | 16.2M | 14.9M |
| Operating Income | -19.7M | -18.2M | -19.3M | -21.6M | -20.4M | -16.7M | -16.2M | -15.0M |
| Other Income / Gains | 2.1M | 2.2M | 2.3M | 2.5M | 2.7M | 3.0M | 3.2M | 3.3M |
| Net Income | -17.6M | -16.0M | -17.0M | -19.1M | -17.7M | -13.7M | -13.0M | -11.8M |
| EPS (Diluted) | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 5.3M | 4.8M | 4.7M | 5.8M | 5.0M | 4.5M | 4.4M | 4.5M |
| Selling And Marketing Expenses | 0 | -70K | 70K | 0 | 0 | 0 | 0 | 76K |
| Selling General And Administrative Expenses | 5.3M | 4.7M | 4.7M | 5.8M | 5.0M | 4.5M | 4.4M | 4.5M |
| Other Expenses | 0 | 14.7M | -14.6M | -152K | 0 | 0 | 0 | 0 |
| Cost And Expenses | 19.7M | 18.2M | 19.3M | 21.6M | 20.4M | 16.7M | 16.2M | 15.0M |
| Interest Income | 2.1M | 2.2M | 2.3M | 2.5M | 2.7M | 3.0M | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 157K | 156K | 155K | 152K | 159K | 149K | 153K | 151K |
| Ebitda | -19.5M | -18.0M | -16.8M | -18.9M | -20.3M | -16.5M | -16.1M | -14.9M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -17.6M | -16.0M | -17.0M | -19.1M | -17.7M | -13.7M | -13.0M | -11.8M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 |
| Weighted Average Shs Out | 61.4M | 57.3M | 57.0M | 56.9M | 56.8M | 56.7M | 56.6M | 56.6M |
| Weighted Average Shs Out Dil | 61.4M | 57.3M | 57.0M | 56.9M | 56.8M | 56.7M | 56.6M | 56.6M |